A soup mix recall issued this month has been updated by the U.S. Food and Drug Administration ( FDA) as a Class I risk, the ...

The U.S. Food and Drug Administration is weighing the need for a regulatory action on bluebird bio's gene therapy for a rare ...

Donald Trump's health team picks includes outspoken critics of the medical establishment and COVID-19 health measures ...

The seafood salad may be of particular risk to those customers who have an allergy or severe sensitivity to soy, the FDA has ...

Dr. Jay Bhattacharya Bhattacharya is a physician and professor at Stanford University School of Medicine, and is a critic of ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for ...

Before Exelexis’ Cabometyx can pass muster with the FDA in its hopeful neuroendocrine tumors indication next April, it will ...

The FDA said it is evaluating the need for additional regulatory action regarding the safety of bluebird bio’s (NASDAQ:BLUE) ...

Outlook Therapeutics’ eye disease drug has failed to match Roche’s Lucentis in a key trial. The biotech brushed off the ...

“Phenylephrine is an oral decongestant and vasoconstrictor,” Valley Health Pharmacist Dr. Aaron Stone. “By that, it means it ...

"The FDA issued three alerts throughout 2024, warning consumers about lead in certain brands of cinnamon products" ...